Source: https://rules.sos.ri.gov/regulations/part/216-10-10-2
Timestamp: 2019-12-08 15:30:37
Document Index: 201896699

Matched Legal Cases: ['§ 23', '§ 2', '§ 2', '§ 2', '§ 2', '§ 2', '§ 2', '§ 42']

216-RICR-10-10-2 ACTIVE RULE
6.	"Rhode Island Cancer Registry" means the Central Registry established within the Department of Health by the Director pursuant to R.I. Gen. Laws §§ 23-1-1, 23-1-18(2), 23-8-1 and 23-12-4 as the statewide Registry for the collection and recording of information on reportable cases as defined in § 2.2(A)(5) of this Part for the purpose of understanding the extent and nature of the diseases among the citizens of the state and to apply preventive and control measures.
A.	Health care facilities and/or health care providers as defined in § 2.2(A)(4) of this Part, shall be responsible to report to the Rhode Island Cancer Registry and the organization and/or agency approved by the Director, each reportable malignant disease indicated by test results, diagnosed and/or confirmed within the health care facility and/or by the health care provider on and after October 1, 1986, each reportable benign neoplasm of the brain or central nervous system indicated by test results, diagnosed and/or confirmed within the health care facility and/or by the health care provider on and after January 1, 1998, and each reportable in-situ carcinomas of the cervix (also known as squamous intraepithelial neoplasia 3: CIN-3) indicated by test results, diagnosed and/or confirmed within the health care facility and/or by the health care provider on and after January 1, 2018, including all histopathology and cytology specimens removed elsewhere but found to be positive for each reportable case upon initial reading or upon consultative reading at the health care facility and/or by the health care provider. Health care facilities and/or health care providers shall report each reportable case treated within the health care facility and/or by the health care provider if that case was diagnosed therein or thereby, or if the treatment therein or thereby is part of the first course of definitive treatment for the case.
B.	Each health care facility and/or health care provider shall electronically submit such data and information on reportable cases and shall meet data element requirements, format, completeness, quality, and timelines prescribed by:
1.	Chapter VII “Record Layout Table” of the “Standards Volume II” of the “Central Cancer Registry Standards” (Version 18, Revised October 12, 2018) published by the North American Association of Central Cancer Registries, incorporated herein by reference, not including any later editions or amendments thereof; and
2.	“Standards for Oncology Registry Entry” (Revised January 1, 2018) published by the Commission on Cancer, incorporated herein by reference, not including any later editions or amendments thereof.
B.	Within one hundred eighty (180) days from the date of a reportable case first seen by provider as defined in § 2.2 of this Part, a health care facility and/or health care provider shall report complete all required information, as specified by the Rhode Island Cancer Registry. The originating health care facility and/or provider shall retain a duplicate copy of submitted information for a two (2) year period from the date of submission. Said information and data shall be submitted in a manner consistent with § 2.4 of this Part.
The Rhode Island Department of Health ("RIDOH") is proposing rulemaking in order to update the electronic submission standards incorporated by reference in §§ 2.4(B)(1) and (2) of the regulations to their most currently available editions, and to revise the format of dates provided in § 2.4(A) of the regulations. Pursuant to R.I. Gen. Laws § 42-35-2.11, RIDOH states that it does not expect the proposed rule to be controversial.
ACTIVE RULE Amendment - effective from 12/14/2018 to Current